Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
[Nicolau syndrome after administration of glatiramer acetate].
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Sanofi MS drug nears green light after pass-the-parcel marathon
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.
American Society for Cell Biology Annual Meeting
The Relative Importance of Baseline Pain, Fatigue, Sleep and Physical Activity: Predicting Change in Depression in Adults with Multiple Sclerosis.
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Fingolimod phosphate promotes the neuroprotective effects of microglia.
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Biomarkers for Brain Disorders: Challenges and Opportunities
A urinary test procedure for identification of cannabidiol in patients undergoing medical therapy with marijuana.
Glatiramer acetate does not protect from acute ischemic stroke in mice.
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Demyelination affects temporal aspects of perception: An optic neuritis study.
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis.
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.

Pages